Have your own idea? Try our Stock Screener
French (CAC) Biotech Industry Analysis
UpdatedMar 25, 2026
DataAggregated Company Financials
Companies22
- 7D-12.2%
- 3M-16.0%
- 1Y303.7%
- YTD-13.0%
Over the last 7 days, the Biotech industry has dropped 7.6%, driven by ABIVAX Société Anonyme declining 5.6%. Meanwhile, Genfit actually outperformed within the industry, gaining 5.7% in the last week. Over the past 12 months, the industry was up 310%. Earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 25 Mar 2026 | €10.5b | €553.4m | -€805,943,156.68 | 12.9x | -13x | 19x |
| Fri, 20 Feb 2026 | €12.0b | €559.6m | -€763,449,727.69 | 13.9x | -15.7x | 21.5x |
| Sun, 18 Jan 2026 | €10.9b | €642.5m | -€695,671,999.16 | 9.5x | -15.7x | 16.9x |
| Tue, 16 Dec 2025 | €2.7b | €636.1m | -€428,464,218.91 | 10.3x | -6.2x | 4.2x |
| Thu, 13 Nov 2025 | €2.5b | €653.5m | -€396,139,021.62 | 10.2x | -6.2x | 3.8x |
| Sat, 11 Oct 2025 | €2.6b | €643.8m | -€445,229,956.05 | 15.9x | -5.8x | 4x |
| Mon, 08 Sep 2025 | €2.3b | €681.6m | -€467,344,360.81 | 13.7x | -5x | 3.4x |
| Wed, 06 Aug 2025 | €2.3b | €664.1m | -€460,064,988.73 | 15.7x | -4.9x | 3.4x |
| Fri, 04 Jul 2025 | €1.9b | €665.5m | -€492,944,452.78 | 16.4x | -3.9x | 2.9x |
| Sun, 01 Jun 2025 | €2.4b | €678.8m | -€675,383,201.68 | 16.5x | -3.5x | 3.5x |
| Tue, 29 Apr 2025 | €2.4b | €634.3m | -€569,139,784.61 | 26x | -4.2x | 3.8x |
| Thu, 27 Mar 2025 | €2.3b | €665.8m | -€495,483,287.57 | 15.3x | -4.6x | 3.4x |
| Sat, 22 Feb 2025 | €2.7b | €650.1m | -€526,247,602.95 | 17x | -5x | 4.1x |
| Mon, 20 Jan 2025 | €2.3b | €650.4m | -€528,311,549.27 | 17.9x | -4.3x | 3.5x |
| Wed, 18 Dec 2024 | €2.3b | €654.5m | -€548,665,233.54 | 17.9x | -4.2x | 3.5x |
| Fri, 15 Nov 2024 | €2.6b | €658.0m | -€545,638,741.26 | 17.4x | -4.8x | 4x |
| Sun, 13 Oct 2024 | €2.7b | €627.4m | -€511,194,935.39 | 19.6x | -5.3x | 4.3x |
| Tue, 10 Sep 2024 | €3.1b | €520.6m | -€580,691,075.97 | 37x | -5.3x | 5.9x |
| Thu, 08 Aug 2024 | €2.9b | €517.1m | -€591,773,047.71 | 37.2x | -4.9x | 5.6x |
| Sat, 06 Jul 2024 | €2.9b | €511.7m | -€566,770,513.45 | 26.2x | -5.1x | 5.7x |
| Mon, 03 Jun 2024 | €3.4b | €503.1m | -€564,341,760.72 | 27.2x | -6.1x | 6.8x |
| Wed, 01 May 2024 | €3.5b | €539.6m | -€701,693,804.50 | 27.3x | -4.9x | 6.4x |
| Fri, 29 Mar 2024 | €3.2b | €502.6m | -€565,573,818.70 | 21.8x | -5.6x | 6.3x |
| Sun, 25 Feb 2024 | €3.1b | €558.8m | -€674,250,189.65 | 21.7x | -4.5x | 5.5x |
| Tue, 23 Jan 2024 | €3.1b | €594.4m | -€684,318,062.00 | 22x | -4.5x | 5.2x |
| Thu, 21 Dec 2023 | €3.3b | €594.2m | -€682,905,461.00 | 22.8x | -4.8x | 5.5x |
| Sat, 18 Nov 2023 | €3.3b | €588.6m | -€671,826,120.00 | 21.9x | -4.9x | 5.6x |
| Mon, 16 Oct 2023 | €3.1b | €806.5m | -€616,906,757.00 | 21.1x | -5.1x | 3.9x |
| Wed, 13 Sep 2023 | €3.9b | €818.0m | -€728,141,503.00 | 23.8x | -5.3x | 4.7x |
| Fri, 11 Aug 2023 | €3.7b | €817.4m | -€723,887,443.00 | 24.5x | -5.1x | 4.5x |
| Sun, 09 Jul 2023 | €3.7b | €818.3m | -€736,211,706.00 | 24.9x | -5x | 4.5x |
| Tue, 06 Jun 2023 | €3.8b | €820.6m | -€744,799,931.00 | 25.3x | -5.1x | 4.7x |
| Thu, 04 May 2023 | €3.3b | €818.4m | -€784,615,860.00 | 29.2x | -4.3x | 4.1x |
| Sat, 01 Apr 2023 | €3.2b | €960.9m | -€692,018,559.00 | 16.5x | -4.6x | 3.3x |
Price to Earnings Ratio
-4.6x
Current Industry PE
- Investors are optimistic on the French Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.8x is lower than the industry's current PS ratio of 19.7x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 17% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | -3.22% | |
| Healthcare | -2.86% | |
| Biotech | -12.19% | |
| Biotech | -12.19% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AELIS Aelis Farma | €1.41 | 12.8% +€2.2m | 30.6% | PS8.2x | |
| ALGEN genOway Société anonyme | €2.52 | 5.9% +€1.3m | -22.5% | PE18.1x | |
| ALVAL Valbiotis | €1.03 | 4.4% +€1.0m | -8.2% | PS26.9x | |
| SIGHT GenSight Biologics | €0.086 | 2.9% +€529.2k | -63.5% | PS19.9x | |
| ALTAO Aton | €0.006 | 3.4% +€165.6k | -36.8% | PS7.6x |